Αρχειοθήκη ιστολογίου

Τρίτη 25 Ιουλίου 2017

HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation Consortium

CONCLUSIONSHER2 mutations were detected in 3% of patients with lung adenocarcinoma in the LCMC. HER2‐directed therapies should be investigated in this subgroup of patients. Cancer 2017. © 2017 American Cancer Society. (Source: Cancer)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2uVJMPY
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,

Αναζήτηση αυτού του ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader